期刊文献+

二联血清标记物用于产前筛查的效果分析

Effect of Second Trimester Prenatal Screening Using Two Serum Markers
下载PDF
导出
摘要 目的探讨孕妇孕中期二联血清标记物用于产前筛查时,对唐氏综合征、18-三体、神经管畸形等出生缺陷疾病检出的实际应用意义。方法应用时间分辨荧光免疫分析技术对孕中期(15~20+6周)35岁以下妇女进行二联血清标记物(AFP、free-βHCG)检测,2T-risk软件计算风险值。对于高危孕妇进行产前诊断。结果共筛查109703例孕妇,其中唐氏综合征高危孕妇4725人,阳性率为4.31%(4725/109703),18-三体高危588人,阳性率0.54%(588/109703),神经管畸形高危861人,阳性率0.78%(861/109703)。接受羊膜腔穿刺术的高危孕妇1952人,发现染色体异常59人,异常检出率为3.02%(59/1952)。结论利用孕妇二项血清标记物进行孕中期产前筛查可有效检出唐氏综合征等染色体异常疾病及其它部分先天性疾病,是预防和降低出生缺陷的有效手段。 Objective To investigate the significance of second trimester prenatal screening on detecting birth defects including Down’s Syndrome, 18-trisomy and nervous tube defects. Methods Applicate time-resolved fluorescence immunoassy to detect two serum markes (AFP and free-β HCG) in second trimester women(15-20+6w), whose ages are≤35 years. Applicate 2T-risk soft ware to calculate risk.Prenatal diagnose high-risk pregnant women. Results There are 4 725 cases of Down’s Syndrome high-risk ones, 588 cases of 18-trisomy high-risk ones and 861cases of nervous tube defects high-risk ones in total screening 109 703 pregnant women, which had positive rate 4.31% (4725/109 703),0.54% (588/109 703), 0.78% (861/109 703) respectively. We found 59 cases fetal chromsome abnormalities within 1952 women who received prenatal diagnosis of amniotic fluid, which had detecting rate 3.02% (59/1952). Conclusion Second trimester prenatal screening by detecting AFP and HCG can predicting chromsome abnormalities and some other birth defects effectively, so it is important and effective way to prevent and decrease birth defects.
出处 《中国产前诊断杂志(电子版)》 2011年第3期4-6,共3页 Chinese Journal of Prenatal Diagnosis(Electronic Version)
关键词 唐氏综合征 18-三体综合征 神经管畸形 出生缺陷 Down’s Syndrome 18-trisomy nerve tube defects birth defects
  • 相关文献

参考文献3

二级参考文献33

  • 1朱宝生,焦存仙,朱姝,董旭东,胡云英,刘云霞,冯怀英,刘娟,唐新华,张云霞,王瑞红,祝杏珍,章晓梅.唐氏综合征发生率及其受产前筛查干预的研究[J].中华妇幼临床医学杂志(电子版),2005,1(1):20-22. 被引量:31
  • 2Hsu JJ, Shieh TT, Hsien FJ. Down syndrome screening in an Asian population using alpha-fetoprotein and free β-hCG: a report of the Taiwan Down syndrome screening group. Obstet Gynecol, 1996,87:943-947.
  • 3Wald NJ, Kennard A, Hackshaw A, et al. Antenatal screening for Down's syndrome. J Med Screen, 1997, 4:151-246.
  • 4Wald N J, Rodeck C, Hackshaw AK, et al. First and Second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) . Health Techol Assess, 2003, 7 : 1-77.
  • 5Watt HC, Wald N J, Smith D, et al. Effect of allowing for ethnic group in prenatal screening for Down's syndrome. Prenat Diagn, 1996, 16:691-698.
  • 6O'brien JE, Dvorin E, Drugan A, et al. Race-ethnicity-specific variation in multiple-marker biochemical screening; alphafetoprotein, hCG, and estriol. Am J Obstet Gynecol, 1997, 89: 355-358.
  • 7Benn PA, Clive JM, Collins R. Medians for second-trimester maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups. Clin Chem, 1997, 43:333-337.
  • 8Lam YH, Ghosh A, Tang MH, et al. Second-trimester maternal serum alpha-fetoprotein and human chrionic gonadotrophin screening for Down's syndrome in Hong Kong. Prenat Diagn, 1998.18:585-589.
  • 9Chao AS, Chao LC, Wu CD, et al. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk : result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population. Acta Obstet Gynecol, 1999,78:393-397.
  • 10Jou HJ, Shyu MK, Chen SM, et al. Maternal serum screening for Down syndrome by using alpha-fetoprotein and human chorionic gnadotrophin in an Asian population. Fetal Diagn Ther, 2000, 15:108-111.

共引文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部